Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers

被引:7
作者
Coulter, Jonathan B. [1 ]
Easwaran, Hariharan [2 ]
机构
[1] Johns Hopkins Univ, Brady Urol Inst, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Canc Genet & Epigenet, Oncol,Sch Med, Baltimore, MD 21231 USA
关键词
POLYCOMB;
D O I
10.1371/journal.pbio.3002081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Development of resistance in castration-resistant prostate cancer (CRPC) involves epigenetic pathways. A new study in PLOS Biology demonstrates that combined therapy targeting enhancer of zeste homolog 2 (EZH2) and histone deacetylases (HDACs) may sensitize CRPC to both epigenetic and standard therapies.
引用
收藏
页数:4
相关论文
共 50 条
[41]   Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A [J].
Tiziana Tonini ;
Luigi Bagella ;
Giuseppina D'Andrilli ;
Pier Paolo Claudio ;
Antonio Giordano .
Oncogene, 2004, 23 :4930-4937
[42]   Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A [J].
Tonini, T ;
Bagella, L ;
D'Andrilli, G ;
Claudio, PP ;
Giordano, A .
ONCOGENE, 2004, 23 (28) :4930-4937
[43]   Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors [J].
Yang, Xiaobao ;
Li, Fengling ;
Konze, Kyle D. ;
Meslamani, Jamel ;
Ma, Anqi ;
Brown, Peter J. ;
Zhou, Ming-Ming ;
Arrowsmith, Cheryl H. ;
Kaniskan, H. Umit ;
Vedadi, Masoud ;
Jin, Jian .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (16) :7617-7633
[44]   LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer [J].
Zhang, Ali ;
Zhao, Jonathan C. ;
Kim, Jung ;
Fong, Ka-wing ;
Yang, Yeqing Angela ;
Chakravarti, Debabrata ;
Mo, Yin-Yuan ;
Yu, Jindan .
CELL REPORTS, 2015, 13 (01) :209-221
[45]   USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization [J].
Park, Jae Min ;
Lee, Jae Eun ;
Park, Chan Mi ;
Kim, Jung Hwa .
MOLECULES AND CELLS, 2019, 42 (01) :17-27
[46]   HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer [J].
Wang, Jianqing ;
He, Chenxi ;
Gao, Peng ;
Wang, Siqing ;
Lv, Ruitu ;
Zhou, Huihui ;
Zhou, Qidong ;
Zhang, Ke ;
Sun, Jian ;
Fan, Caibin ;
Ding, Guanxiong ;
Lan, Fei .
ONCOGENE, 2020, 39 (06) :1335-1346
[47]   EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors [J].
Fillmore, Christine M. ;
Xu, Chunxiao ;
Desai, Pooja T. ;
Berry, Joanne M. ;
Rowbotham, Samuel P. ;
Lin, Yi-Jang ;
Zhang, Haikuo ;
Marquez, Victor E. ;
Hammerman, Peter S. ;
Wong, Kwok-Kin ;
Kim, Carla F. .
NATURE, 2015, 520 (7546) :239-U261
[48]   EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin [J].
Tong, Z-T ;
Cai, M-Y ;
Wang, X-G ;
Kong, L-L ;
Mai, S-J ;
Liu, Y-H ;
Zhang, H-B ;
Liao, Y-J ;
Zheng, F. ;
Zhu, W. ;
Liu, T-H ;
Bian, X-W ;
Guan, X-Y ;
Lin, M. C. ;
Zeng, M-S ;
Zeng, Y-X ;
Kung, H-F ;
Xie, D. .
ONCOGENE, 2012, 31 (05) :583-594
[49]   Nano particle loaded EZH2 inhibitors: Increased efficiency and reduced toxicity for malignant solid tumors [J].
Guo, Yunyun ;
Huang, Jiaqi ;
Lin, Meng ;
Yin, Qianqian ;
Zhang, Tengrui ;
Guo, Zhengyang ;
Tang, Yuanjun ;
Cheng, Rui ;
Wang, Yan ;
Peng, Yiwei ;
Cao, Xuedi ;
Wang, Yuqing ;
Qi, Xianrong ;
Liu, Yang ;
Xue, Lixiang .
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2025, 13 (02) :156-169
[50]   Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth [J].
Garapaty-Rao, Shivani ;
Nasveschuk, Christopher ;
Gagnon, Alexandre ;
Chan, Eric Y. ;
Sandy, Peter ;
Busby, Jennifer ;
Balasubramanian, Srividya ;
Campbell, Robert ;
Zhao, Feng ;
Bergeron, Louise ;
Audia, James E. ;
Albrecht, Brian K. ;
Harmange, Jean-Christophe ;
Cummings, Richard ;
Trojer, Patrick .
CHEMISTRY & BIOLOGY, 2013, 20 (11) :1329-1339